Patents by Inventor Willi Cawello

Willi Cawello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multi-day patch for the transdermal administration of rotigotine
    Patent number: 11389410
    Abstract: The present invention relates to a transdermal therapeutic system, comprising (a) a backing layer, (b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and (c) a release liner, wherein the self-adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer, a kit comprising two transdermal therapeutic systems of the present invention as well as a method for the preparation of the transdermal therapeutic system of the present invention.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: July 19, 2022
    Assignee: LTS Lohmann Therapie-Systeme AG
    Inventors: Willi Cawello, Aurelia Lappert, Kristina Kassner, Hans-Michael Wolff, Walter Müller, Johannes Josef Leonhard, Marco Emgenbroich
  • Multi-Day Patch for the Transdermal Administration of Rotigotine
    Publication number: 20220151949
    Abstract: The present invention relates to a transdermal therapeutic system formed from (a) a backing layer, (b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and (c) a release liner, in which the self-adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer; a kit containing two transdermal therapeutic systems of the present invention; and methods for the preparation of the transdermal therapeutic system of the present invention. The present invention further relates to methods of treatment based upon the application of the inventive transdermal therapeutic systems once or twice weekly via systems adapted to allow for the transdermal administration of therapeutically effective amounts of rotigotine for at least 3 days.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Applicant: LTS Lohmann Therapie-Systeme AG
    Inventors: Willi CAWELLO, Aurelia LAPPERT, Kristina KASSNER, Hans-Michael WOLFF, Walter MÜLLER, Johannes Josef LEONHARD, Marco EMGENBROICH
  • DAILY FORMULATION OF LACOSAMIDE
    Publication number: 20190054009
    Abstract: A modified release formulation of lacosamide suitable for once-daily administration.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Applicant: UCB Pharma GmbH
    Inventors: Willi CAWELLO, Martin Alexander SCHUBERT
  • LACOSAMIDE CONTROLLED RELEASE FORMULATION
    Publication number: 20190008758
    Abstract: A modified release formulation of lacosamide suitable for once-daily administration.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 10, 2019
    Applicant: UCB Pharma GmbH
    Inventors: Willi CAWELLO, Martin Alexander SCHUBERT
  • Daily formulation of lacosamide
    Patent number: 10149818
    Abstract: A modified release formulation of lacosamide suitable for once-daily administration.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 11, 2018
    Assignee: UCB PHARMA GMBH
    Inventors: Willi Cawello, Martin Alexander Schubert
  • Multi-Day Patch for the Transdermal Administration of Rotigotine
    Publication number: 20150290142
    Abstract: The present invention relates to a transdermal therapeutic system, comprising (a) a backing layer, (b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and (c) a release liner, wherein the self-adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer, a kit comprising two transdermal therapeutic systems of the present invention as well as a method for the preparation of the transdermal therapeutic system of the present invention.
    Type: Application
    Filed: November 21, 2013
    Publication date: October 15, 2015
    Inventors: Willi Cawello, Aurelia Lappert, Kristina Kassner, Hans-Michael Wolff, Walter Müller, Johannes Josef Leonhard, Marco Emgenbroich
  • FORMULATION OF LACOSAMIDE
    Publication number: 20150104507
    Abstract: A modified release formulation of lacosamide.
    Type: Application
    Filed: October 21, 2014
    Publication date: April 16, 2015
    Inventors: Willi CAWELLO, Martin Alexander SCHUBERT
  • ONCE DAILY FORMULATION OF LACOSAMIDE
    Publication number: 20130251803
    Abstract: A modified release formulation of lacosamide suitable for once-daily administration.
    Type: Application
    Filed: December 1, 2011
    Publication date: September 26, 2013
    Applicant: UCB PHARMA GMBH
    Inventors: Willi Cawello, Martin Alexander Schubert
  • FORMULATION OF LACOSAMIDE
    Publication number: 20130251813
    Abstract: A modified release formulation of lacosamide.
    Type: Application
    Filed: December 1, 2011
    Publication date: September 26, 2013
    Applicant: UCB PHARMA GMBH
    Inventors: Willi Cawello, Martin Alexander Schubert